In-Depth Examination Of 10 Analyst Recommendations For CME Gr
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for CME Group (NASDAQ:CME) over the past three months, with a range of bullish to bearish perspectives. The average 12-month price target has decreased to $208.7 from $214.00. Recent analyst actions include both raises and lowers in price targets, reflecting varied expectations for CME's future performance. Key financial metrics show strong net margins but lower ROE and ROA compared to industry averages.
August 15, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
CME Group (NASDAQ:CME) has received mixed analyst ratings over the past three months, with a decrease in the average 12-month price target to $208.7. Financial metrics show strong net margins but lower ROE and ROA compared to industry averages.
The mixed analyst ratings and the decrease in the average price target suggest uncertainty about CME's short-term performance. While the company shows strong net margins, its lower ROE and ROA compared to industry averages may concern investors. The overall impact on the stock price is likely to be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100